Zynex inc.
Financial Information. This section of the Zynex Medical InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. Please note: All data in this section is provided by a 3rd party provider and may be delayed up to ...
Zynex Inc. (ZYXI) is expected to report $0.1 for Q3. Get Email and Text Alerts for (OTCMKTS:ZYXI) News, Short Squeeze, Breakout and More Instantly...About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in …ENGLEWOOD, Colo., May 4, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI ), announced today the pricing of its previously announced private offering of $52.5 million aggregate principal ...Business Profile for Zynex Medical, Inc. Medical Equipment. At-a-glance. Contact Information. 9655 Maroon Cir. Englewood, CO 80112-5914. Visit Website (800) 495-6670. Want a quote from this business?
Nov 24, 2023 · Zynex, Inc. (NASDAQ:ZYXI) posted its quarterly earnings data on Thursday, October, 26th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. The firm had revenue of $49.92 million for the quarter, compared to analyst estimates of $49.50 million.
Zynex, Inc. (NASDAQ:NASDAQ:ZYXI) Q1 2023 Earnings Conference Call April 27, 2023 4:15 PM ETCompany ParticipantsLouisa Smith - Investor RelationsThomas...As of November 09, 2023, Zynex Inc. had a $306.8 million market capitalization, putting it in the 51st percentile of companies in the Advanced Medical Equipment & Technology industry. Currently, Zynex Inc.’s price-earnings ratio is 20.7. Zynex Inc.’s trailing 12-month revenue is $185.8 million with a 8.6% profit margin.
Aug 9, 2023 · Zynex. 09 Aug, 2023, 09:15 ET. ENGLEWOOD, Colo., Aug. 9, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI ), an innovative medical technology company specializing in the manufacture and sale of non ... Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Corporate Governance Zynex, Inc.’s ISS Governance QualityScore as of November 1, 2023 is 7.WebZynex, Inc. is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis and cardiac monitoring. Thomas Sandgaard founded Zynex Medical in 1996. The company is based in unincorporated Douglas County, Colorado.May 1, 2023 · Zynex Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive. Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today. Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. Zynex ranked 23rd in the Top 100 Healthcare Technology Report. Zynex was recognized by The Denver Business Journal as the 50th largest public company in Colorado based on revenue. Based in Englewood, Colorado, Zynex Medical is always looking to expand the team nationwide with passionate talent at all stages of their careers.
ENGLEWOOD, Colo., May 3, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced its intent to offer, subject to market conditions and other factors, $50 million aggregate principal amount of its convertible senior notes due 2026 (the "Notes") in a private offering (the "Notes Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule ...
Fax your prescription to 866-791-2026 . If you are with a doctor’s office or physical therapy clinic, please include a cover sheet with the clinic/practice name with your fax. 2. Zynex will take care of the rest! We will call to review insurance information, ship the device to your doorstep, and provide instructions to use it.
JetStream (Discontinued) Patented ATC™ Measures and regulates temperature to provide therapeutic hot and cold therapy without manual adjustment. We specialize in offering patients simple and safe ways to manage their pain to improve their quality of life. Opioid free and prescription strength. Mar 13, 2023 · About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser ... Dec 23, 2021 · About Zynex, Inc. Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation as well as developing noninvasive patient ... Nov 13, 2023 · Zynex, Inc. announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the M-Wave Neuromuscular Electrical Stimulation ("NMES") device. The M-Wave is set to replace its predecessor, the E-Wave, which has been fundamental in NMES treatments across the U.S. since 1998. Lincare Inc. sells oxygen and infusion systems for in-home respiratory therapy. Some of the oxygen systems include concentrators, portable and stationary liquid oxygen systems and high-pressure systems.Zynex, Inc. raised $52.5 million via five percent convertible notes due in 2026 in May of this year. Verdict: Zynex made 44 cents a share of profit in FY2022 on just over $158 million in sales.Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year Zynex, Inc. (NASDAQ: ZYXI), an innovative medical …Web
Zynex, Inc. develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. The Company's devices are intended for pain management and provide rehabilitation and through the utilization of non ...Zynex Recognized in Top 100 Healthcare Technologies Companies for Second Year in a Row Read More. OCT 12, 2023 Zynex, Inc Sets Third Quarter 2023 Earnings CallZynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year Zynex, Inc. (NASDAQ: ZYXI), an innovative medical …WebMay 1, 2023 · Zynex Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive. Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today. Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. 24 Mei 2023 ... As The Capitol Forum has previously reported, Zynex often ships an excessive amount of reusable supplies in order to bill insurers more, a ...
Zynex's CEO is Thomas Sandgaard, appointed in Jan 1996, has a tenure of 27.83 years. total yearly compensation is $1.36M, comprised of 42.3% salary and 57.7% bonuses, including company stock and options. directly owns 43.08% of the company’s shares, worth $139.33M. The average tenure of the management team and the board of directors is 3 ...
Zynex Inc (NASDAQ:ZYXI) Q3 2023 revenue increased by 20% to $49.9 million, compared to $41.5 million in the prior year quarter.The company reported an EPS of $0.10 for the quarter. Zynex's pain ...ZYXI stock had an impressive performance on November 13, 2023. According to CNN Money, there are four analysts who have offered 12-month price forecasts for Zynex Inc. The median target price is $18.25, with a high estimate of $27.00 and a low estimate of $13.00. The current consensus among the four polled investment analysts is …Tracfone Wireless Inc is one of the leading wireless communication providers in the United States. With a wide range of affordable plans and extensive coverage, Tracfone has garnered a loyal customer base over the years.About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com. Forward-Looking …Discover historical prices for ZYXI stock on Yahoo Finance. View daily, weekly or monthly format back to when Zynex, Inc. stock was issued.Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...Zynex Inc. , which belongs to the Zacks Medical - Products industry, posted revenues of $49.92 million for the quarter ended September 2023, surpassing the Zacks Consensus Estimate by 0.84%.Zynex Inc. , which belongs to the Zacks Medical - Products industry, posted revenues of $49.92 million for the quarter ended September 2023, surpassing the Zacks Consensus Estimate by 0.84%.Zynex Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive. Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today. Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate.NeuroMove™ is FDA-cleared for stroke rehabilitation, and its use has dramatically ameliorated functional impairments in stroke survivors in many clinical studies and in the clinical practice. It is sophisticated enough to employ in the clinic, yet simple enough for patients to use at home. Utilizing the device 30 minutes daily for 4–5 ...
Zynex, Inc. (NASDAQ:ZYXI) posted its quarterly earnings data on Thursday, October, 26th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. The firm had revenue of $49.92 million for the quarter, compared to analyst estimates of $49.50 million.
ZINEX CORPORATION. Since 1989, the Zinex Corporation has been an industry leader in developing environmentally-friendly plating chemistry suitable for production baths in both “job” and “captive” shops. ZINEX plating chemicals do not contain cyanide, chrome, chelators, organics, selenium, lead or hydroxides; Additionally, these processes are user …
Zynex shares are up ~100x since late 2016 as retail investors buy into a story of rapid revenue and earnings growth. However, we believe Zynex is dependent on an abusive pricing strategy ...Zynex, Inc. announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the M-Wave Neuromuscular Electrical Stimulation ("NMES") device. The M-Wave is set to replace its predecessor, the E-Wave, which has been fundamental in NMES treatments across the U.S. since 1998.Apr 29, 2023 · Zynex, Inc. (NASDAQ:NASDAQ:ZYXI) Q1 2023 Earnings Conference Call April 27, 2023 4:15 PM ETCompany ParticipantsLouisa Smith - Investor RelationsThomas... Aug 9, 2023 · Zynex. 09 Aug, 2023, 09:15 ET. ENGLEWOOD, Colo., Aug. 9, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI ), an innovative medical technology company specializing in the manufacture and sale of non ... This report compares the performances of Zynex Inc. (ZYXI) and BioLife Solutions, Inc. (BLFS) stocks. After reading this report, you will learn the differences in growth, annual returns, dividend payouts, splits, biggest gains etc. The timeframe of analysis is between '11-26-2013' and '11-24-2023'. In total, there are 7 sections in this report.Nov 13, 2023 · --Zynex, Inc., an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today ... Oct 22, 2019 · Zynex shares are up ~100x since late 2016 as retail investors buy into a story of rapid revenue and earnings growth. However, we believe Zynex is dependent on an abusive pricing strategy ... Zynex, Inc. was founded by Thomas Sandgaard in 1996, when he founded two privately held companies that eventually were folded into Zynex, Inc. Zynex, Inc., a Nevada corporation, is the parent company of and conducts business within five active and inactive subsidiaries.Discover historical prices for ZYXI stock on Yahoo Finance. View daily, weekly or monthly format back to when Zynex, Inc. stock was issued.ZYNEX, INC., f/k/a ZYNEX MEDICAL HOLDINGS, INC., THOMAS SANDGAARD and FRITZ G. ALLISON, Defendants. Civil Action No. 09-cv-00816-MSK-MJW ROBERT HANRATTY ...Oct 22, 2019 · Zynex shares are up ~100x since late 2016 as retail investors buy into a story of rapid revenue and earnings growth. However, we believe Zynex is dependent on an abusive pricing strategy ... Mar 6, 2023 · ENGLEWOOD, Colo., March 6, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will postpone the release of its fourth quarter and full year financial results and conference call initially ...
Zynex, Inc. (ZYXI) to weigh options, including possible sale - Bloomberg October 30, 2023 5:38 PM EDT Tweet. Send to a Friend. Zynex, Inc. (NASDAQ ... This is a premium only article.About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser ...Zynex, Inc. Company Profile | Englewood, CO | Competitors, Financials & Contacts - Dun & Bradstreet.Instagram:https://instagram. how much is a maybach suvrecommended reitssell xbox 360 games for cashbreeze insurance reviews Zynex Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View ZYXI financial statements in full. odfl newsblv dividend About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com. budwesier stock ENGLEWOOD, Colo., Oct. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI ), an innovative medical technology company specializing in the manufacture and …WebENGLEWOOD, Colo., March 13, 2023 / PRNewswire / -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended December 31, 2022.Apr 27, 2023 · Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...